Sania Therapeutics Is A Biotechnology Company Dedicated To Developing Precision Therapies For Neural Circuit Dysfunctionsfounded With Technology From University College Londonthe Company Launched Publicly In May 2023 After A Successful Series Seed Financing Roundsania Focuses On Patient Needs And Translational Science To Create Innovative Genetic Medicine Solutions The Companyae S Core Offerings Include Proprietary Platforms That Feature Targeted Delivery Systems Using Evolved Adeno Associated Virusesaavsfor Precise Therapeutic Deliveryand Tuneable Ion Channels Designed To Correct Dysfunctional Neural Excitationtheir Pipeline Includes A Lead Program Targeting Motor Disorders And Additional Programs Leveraging Their Platform Capabilitiessania Therapeutics Aims To Restore Proper Neural Activityaddressing A Wide Range Of Disorders Both Within And Beyond Neurologywith A Commitment To Patient Centered Carehigh Performanceand Collaborationsania Therapeutics Seeks To Redefine Treatment Paradigms For Complex Nervous System Disorders
